BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 19208428)

  • 1. Survival after Hodgkin lymphoma: causes of death and excess mortality in patients treated in 8 consecutive trials.
    Favier O; Heutte N; Stamatoullas-Bastard A; Carde P; Van't Veer MB; Aleman BM; Noordijk EM; Thomas J; Fermé C; Henry-Amar M;
    Cancer; 2009 Apr; 115(8):1680-91. PubMed ID: 19208428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term survival in Hodgkin's disease relative impact of mortality, second tumors, infection, and cardiovascular disease.
    Mauch PM; Kalish LA; Marcus KC; Shulman LN; Krill E; Tarbell NJ; Silver B; Weinstein H; Come S; Canellos GP; Coleman CN
    Cancer J Sci Am; 1995; 1(1):33-42. PubMed ID: 9166452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term cause-specific mortality among five-year survivors of childhood cancer.
    Cardous-Ubbink MC; Heinen RC; Langeveld NE; Bakker PJ; Voûte PA; Caron HN; van Leeuwen FE
    Pediatr Blood Cancer; 2004 Jun; 42(7):563-73. PubMed ID: 15127410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term cause-specific mortality of patients treated for Hodgkin's disease.
    Aleman BM; van den Belt-Dusebout AW; Klokman WJ; Van't Veer MB; Bartelink H; van Leeuwen FE
    J Clin Oncol; 2003 Sep; 21(18):3431-9. PubMed ID: 12885835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term events in adult patients with clinical stage IA-IIA nonbulky Hodgkin's lymphoma treated with four cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine and adjuvant radiotherapy: a single-institution 15-year follow-up.
    Brusamolino E; Baio A; Orlandi E; Arcaini L; Passamonti F; Griva V; Casagrande W; Pascutto C; Franchini P; Lazzarino M
    Clin Cancer Res; 2006 Nov; 12(21):6487-93. PubMed ID: 17085663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcome after radiotherapy alone for lymphocyte-predominant Hodgkin lymphoma: a retrospective multicenter study of the Australasian Radiation Oncology Lymphoma Group.
    Wirth A; Yuen K; Barton M; Roos D; Gogna K; Pratt G; Macleod C; Bydder S; Morgan G; Christie D
    Cancer; 2005 Sep; 104(6):1221-9. PubMed ID: 16094666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Twenty-year disease and treatment-associated mortality rates of patients with Hodgkin lymphoma of clinical stages IIIB and IV prospectively treated with 3-month anthracycline-based chemotherapy followed by extended high-dose radiation.
    Sénécal D; Jais JP; Desablens B; Berthou C; Casassus P; Moles MP; Delwail V; Gastinne T; Colonna P; Andrieu JM
    Cancer; 2008 Feb; 112(4):846-55. PubMed ID: 18072259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mortality after cure of soft-tissue sarcoma treated with conservation surgery and radiotherapy.
    Guadagnolo BA; Zagars GK; Ballo MT; Strom SS; Pollock RE; Benjamin RS
    Cancer; 2008 Jul; 113(2):411-8. PubMed ID: 18506733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical presentation and outcomes of lymphocyte-predominant Hodgkin disease at the University of Florida.
    Chera BS; Olivier K; Morris CG; Lynch JW; Mendenhall NP
    Am J Clin Oncol; 2007 Dec; 30(6):601-6. PubMed ID: 18091054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mortality after cure of testicular seminoma.
    Zagars GK; Ballo MT; Lee AK; Strom SS
    J Clin Oncol; 2004 Feb; 22(4):640-7. PubMed ID: 14726503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased long-term mortality among survivors of acute carbon monoxide poisoning.
    Hampson NB; Rudd RA; Hauff NM
    Crit Care Med; 2009 Jun; 37(6):1941-7. PubMed ID: 19384195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mortality and causes of death in primary Sjögren's syndrome: a prospective cohort study.
    Theander E; Manthorpe R; Jacobsson LT
    Arthritis Rheum; 2004 Apr; 50(4):1262-9. PubMed ID: 15077310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Excess mortality and cause of death in a cohort of Norwegian multiple sclerosis patients.
    Smestad C; Sandvik L; Celius EG
    Mult Scler; 2009 Nov; 15(11):1263-70. PubMed ID: 19812114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hodgkin lymphoma in Tyrol-a population-based study.
    Fong D; Steurer M; Greil R; Gunsilius E; Spizzo G; Gastl G; Tzankov A
    Ann Hematol; 2009 May; 88(5):449-56. PubMed ID: 18846373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long term mortality of five-year survivors of childhood cancer in Rhône-Alpes region].
    Trombert-Paviot B; Frappaz D; Casagranda L; Plantaz D; Bertrand Y; Stephan JL; Berger C; Freycon F
    Rev Epidemiol Sante Publique; 2008 Dec; 56(6):383-90. PubMed ID: 19013040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer risk in female survivors of Hodgkin's lymphoma: lower risk after smaller radiation volumes.
    De Bruin ML; Sparidans J; van't Veer MB; Noordijk EM; Louwman MW; Zijlstra JM; van den Berg H; Russell NS; Broeks A; Baaijens MH; Aleman BM; van Leeuwen FE
    J Clin Oncol; 2009 Sep; 27(26):4239-46. PubMed ID: 19667275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term excess mortality in 623 patients with brain arteriovenous malformations.
    Laakso A; Dashti R; Seppänen J; Juvela S; Väärt K; Niemelä M; Sankila R; Hernesniemi JA
    Neurosurgery; 2008 Aug; 63(2):244-53; discussion 253-5. PubMed ID: 18797354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hodgkin lymphoma-related vanishing bile duct syndrome and idiopathic cholestasis: statistical analysis of all published cases and literature review.
    Ballonoff A; Kavanagh B; Nash R; Drabkin H; Trotter J; Costa L; Rabinovitch R
    Acta Oncol; 2008; 47(5):962-70. PubMed ID: 17906981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term effects of high-dose chemotherapy and radiation for relapsed and refractory Hodgkin's lymphoma.
    Goodman KA; Riedel E; Serrano V; Gulati S; Moskowitz CH; Yahalom J
    J Clin Oncol; 2008 Nov; 26(32):5240-7. PubMed ID: 18809615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular disease a hazard despite improved prognosis in patients with systemic lupus erythematosus: results from a Swedish population based study 1964-95.
    Björnådal L; Yin L; Granath F; Klareskog L; Ekbom A
    J Rheumatol; 2004 Apr; 31(4):713-9. PubMed ID: 15088296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.